Literature DB >> 18321492

Recanalization and particle exclusion after embolization of uterine arteries in sheep: a long-term study.

Alexandre Laurent1, Michel Wassef, Julien Namur, Jacques Martal, Denis Labarre, Jean-Pierre Pelage.   

Abstract

OBJECTIVE: To compare the long-term evolution of uterine arteries after embolization with the two most commonly used embolic agents for fibroid embolization: nonspherical polyvinyl alcohol (PVA) particles and trisacryl gelatin microspheres (TGMS).
DESIGN: Prospective study.
SETTING: University-based interventional radiology, pathology, and reproductive physiology units. ANIMAL(S): Two groups of 10 sheep embolized in the uterine artery. INTERVENTION(S): Embolization of the uterine artery with either 600-1000 microm nonspherical polyvinyl alcohol (PVA) particles or with 700-900 microm trisacryl gelatin microspheres (TGMS). Animals were synchronized and naturally inseminated. Animals were killed at 26 months. MAIN OUTCOME MEASURE(S): Uteri were examined pathologically for vessel size, site of occlusion, recanalization rate of vessels, and particle location within the vascular wall. RESULT(S): The PVA particles were more numerous in the vessels' lumen than the TGMS particles (13.3 +/- 20.8 vs. 2.5 +/- 2.7), were located more proximally than TGMS (97% vs. 68% in the trunk and first branches of the uterine artery), and were found almost exclusively in the intima (99.2%). In contrast, 54.4% of the TGMS particles were found in the intima, and 45.6% partially or totally excluded. The rate of recanalization was not statistically significantly different for PVA and TGMS (65.2% vs. 60.6%). CONCLUSION(S): The long-term evolution of uterine arteries was different after uterine artery embolization with PVA and TGMS because PVA particles formed large-sized aggregates that occluded proximal vessels and remained in the vessel intima. Microspheres occluded more distal vessels, and about 50% of them were partially or totally excluded from the vessel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321492     DOI: 10.1016/j.fertnstert.2007.12.015

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

2.  Temperature-sensitive poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel as an embolic agent: distribution, durability of vascular occlusion, and inflammatory reactions in the renal artery of rabbits.

Authors:  H Zhao; C Zheng; G Feng; Y Zhao; H Liang; H Wu; G Zhou; B Liang; Y Wang; X Xia
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

Review 3.  Particle Distribution in Embolotherapy, How Do They Get There? A Critical Review of the Factors Affecting Arterial Distribution of Embolic Particles.

Authors:  Reza Talaie; Pooya Torkian; Omid Amili; Yasmina Aboufirass; Nassir Rostambeigi; Hamed Jalaeian; Jafar Golzarian
Journal:  Ann Biomed Eng       Date:  2022-05-06       Impact factor: 3.934

4.  Microvascular Perfusion Changes following Transarterial Hepatic Tumor Embolization.

Authors:  Carmen Gacchina Johnson; Karun V Sharma; Elliot B Levy; David L Woods; Aaron H Morris; John D Bacher; Andrew L Lewis; Bradford J Wood; Matthew R Dreher
Journal:  J Vasc Interv Radiol       Date:  2015-08-28       Impact factor: 3.464

5.  Recurrence of a Refractory Chronic Subdural Hematoma after Middle Meningeal Artery Embolization That Required Craniotomy.

Authors:  Hideo Chihara; Hirotoshi Imamura; Takenori Ogura; Hidemitsu Adachi; Yukihiro Imai; Nobuyuki Sakai
Journal:  NMC Case Rep J       Date:  2014-05-09

Review 6.  Updated approaches for management of uterine fibroids.

Authors:  Aymara Mas; Marta Tarazona; Joana Dasí Carrasco; Gloria Estaca; Ignacio Cristóbal; Javier Monleón
Journal:  Int J Womens Health       Date:  2017-09-05

Review 7.  Endoluminal occlusion devices: technology update.

Authors:  Tobias Zander; Samantha Medina; Guillermo Montes; Lourdes Nuñez-Atahualpa; Michel Valdes; Manuel Maynar
Journal:  Med Devices (Auckl)       Date:  2014-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.